Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Non-Small Cell Lung Cancer With EGFR T790M Mutation × osimertinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 26 Lung Neoplasms 5 NSCLC 2 Meningeal Carcinomatosis 2 Bronchial Neoplasms 2 Brain Neoplasms 2 Non-Small Cell Lung Cancer With EGFR T790M Mutation 1 Neurocognitive 1 Advanced Non-small Cell Lung Cancer 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03257124 2021-08-16

Study of AZD9291 in NSCLC Patients Harboring T790M Mutation Who Failed EGFR TKI and With Brain and/or LMS

Samsung Medical Center

Phase 2 Unknown

Non-Small Cell Lung Cancer With EGFR T790M Mutation

Data powered by HemOnc (CC BY 4.0) Colophon ⚡